InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Clackson Timothy P, Directeur, Président et CEO. Insider active across 4 companies, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 10 reports have been published. Split: 2 buys · 1 sell. Total volume traded: €39k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 23 July 2025 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Clackson Timothy P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
47,330 shares@ US$0.36100.0% of flowCommon StockSEC:0001415889-25-020238:0
15,777 shares0Common StockSEC:0001415889-23-012907:0
2,500 shares@ US$6.79827.0% of flowCommon StockSEC:0001104659-22-118549:0
Canonical exit: 9 Feb 2023 (T+90)
23,590 sharesCommon StockSEC:0000899243-22-033647:0
31,553 shares0Common StockSEC:0001209191-22-038758:0
4,500 shares0Common StockSEC:0000899243-22-021662:0
2,600 shares@ US$9.762157.4% of flowCommon StockSEC:0000899243-21-049429:0
Canonical exit: 21 Mar 2022 (T+90)
2,750 shares0Common StockSEC:0000899243-21-025092:0
29,333 sharesCommon StockSEC:0001127602-16-039317:0
14,667 sharesCommon StockSEC:0001127602-16-039317:1
10 of 10 declarations
About Clackson Timothy P
CLACKSON TIMOTHY P is Director, President and CEO. He has 10 filings in total. In the recent sample of 10 filings, the reported buy volume is EUR 39181 and the reported sell volume is EUR 0, and the filings run from 2016-02-03 to 2025-07-24. His listed companies are Elevation Oncology, Inc., Forma Therapeutics Holdings, Inc., Theseus Pharmaceuticals, Inc. and ARIAD PHARMACEUTICALS INC.
